ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

VVOS Vivos Therapeutics Inc

2.12
-0.08 (-3.64%)
May 22 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 32,800
Bid Price 2.10
Ask Price 2.12
News -
Day High 2.245

Low
1.9601

52 Week Range

High
48.79

Day Low 2.085
Share Name Share Symbol Market Stock Type
Vivos Therapeutics Inc VVOS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.08 -3.64% 2.12 18:44:07
Open Price Low Price High Price Close Price Previous Close
2.20 2.085 2.245 2.13 2.20
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
231 32,800 US$ 2.18 US$ 71,555 - 1.9601 - 48.79
Last Trade Type Quantity Price Currency
18:44:27 formt 300 US$ 2.12 USD

Vivos Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.55M 1.20M - 13.8M -13.58M -11.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vivos Therapeutics News

Date Time Source News Article
5/20/202412:04GlobeNewswire Inc.Consolidated Water Comments on ISS and Glass Lewis Reports..
5/17/202415:43Edgar (US Regulatory)Form 8-K - Current report
5/15/202413:54Edgar (US Regulatory)Form 8-K - Current report
5/14/202415:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/202415:05GlobeNewswire Inc.Vivos Therapeutics Reports First Quarter 2024 Financial..
5/14/202406:30GlobeNewswire Inc.Vivos Therapeutics Schedules Release of First Quarter 2024..
4/09/202406:30GlobeNewswire Inc.Vivos Therapeutics’ Flagship CARE Oral Medical Devices..
3/28/202415:05GlobeNewswire Inc.Vivos Therapeutics Reports Fourth Quarter and Full Year 2023..
3/28/202406:30GlobeNewswire Inc.Vivos Therapeutics Schedules Release of Fourth Quarter and..
2/15/202407:55Edgar (US Regulatory)Form 8-K - Current report
2/15/202407:00GlobeNewswire Inc.Vivos Therapeutics Announces Exercise of Warrants for..
2/14/202416:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VVOS Message Board. Create One! See More Posts on VVOS Message Board See More Message Board Posts

Historical VVOS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.132.342.062.2244,921-0.01-0.47%
1 Month2.572.721.96012.3572,391-0.45-17.51%
3 Months4.866.231.96013.11181,393-2.74-56.38%
6 Months4.9948.791.960128.94632,191-2.87-57.52%
1 Year8.5348.791.960111.481,897,238-6.41-75.15%
3 Years140.75177.251.960150.411,374,670-138.63-98.49%
5 Years176.75360.251.960156.681,246,153-174.63-98.80%

Vivos Therapeutics Description

Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists.

Your Recent History

Delayed Upgrade Clock